Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brynn E Marks

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Hormone Research in Paediatrics|October 15, 2024
Ketone Management in Pediatric Diabetes Centers in the USA: Current Practices and a Call for Improved StandardizationBrynn E Marks, Seema Meighan, Emily E Fivekiller, et al.
Journal of Clinical & Translational Endocrinology|December 17, 2021
Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systemsBrynn E Marks, Kristen M Williams, Jordan S Sherwood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 12, 2025
A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People with Type 1 DiabetesSonia Gera, Jaisree Iyer, Seema Meighan, et al.
Journal of Clinical & Translational Endocrinology|November 28, 2025
Alternative approaches to glucose measurements during oral glucose tolerance testing in youth with cystic fibrosis: a mixed methods pilot studySeema Meighan, Robert J Gallop, Melissa S Putman, et al.
Diabetes Technology & Therapeutics|May 10, 2025
The Effect of Omnipod 5 Automated Insulin Delivery on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related DiabetesKevin J Scully, Michelle Reed, Julia Douvas, et al.
Diabetes Technology & Therapeutics|May 28, 2024
The Type of Patient Training Does Not Impact Outcomes in the First 90 Days of Automated Insulin Delivery UseSeema Meighan, Julia L Douvas, Andrew Rearson, et al.
Diabetes Technology & Therapeutics|January 26, 2019
Pediatric Endocrinology Trainees' Education and Knowledge About Insulin Pumps and Continuous Glucose MonitorsBrynn E Marks, Joseph I Wolfsdorf, Gretchen Waldman, et al.
Contemporary Clinical Trials Communications|January 26, 2023
Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort studyJody B Grundman, Shideh Majidi, Amanda Perkins, et al.
Diabetes Technology & Therapeutics|November 7, 2025
Real-World Duration of Dexcom G7 Continuous Glucose Monitor Wear in Youth and Young Adults with Type 1 DiabetesBrynn E Marks, Andrew Rearson, Melissa Andrews Rearson, et al.
Journal of Clinical & Translational Endocrinology|June 5, 2023
Differences in positive expectancy of hybrid closed loop (HCL) insulin delivery systems do not explain racial differences in HCL useJody B Grundman, Amanda Perkins, Maureen Monaghan, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Hormone Research in Paediatrics|October 15, 2024
Ketone Management in Pediatric Diabetes Centers in the USA: Current Practices and a Call for Improved StandardizationBrynn E Marks, Seema Meighan, Emily E Fivekiller, et al.
Journal of Clinical & Translational Endocrinology|December 17, 2021
Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systemsBrynn E Marks, Kristen M Williams, Jordan S Sherwood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 12, 2025
A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People with Type 1 DiabetesSonia Gera, Jaisree Iyer, Seema Meighan, et al.
Journal of Clinical & Translational Endocrinology|November 28, 2025
Alternative approaches to glucose measurements during oral glucose tolerance testing in youth with cystic fibrosis: a mixed methods pilot studySeema Meighan, Robert J Gallop, Melissa S Putman, et al.
Diabetes Technology & Therapeutics|May 10, 2025
The Effect of Omnipod 5 Automated Insulin Delivery on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related DiabetesKevin J Scully, Michelle Reed, Julia Douvas, et al.
Diabetes Technology & Therapeutics|May 28, 2024
The Type of Patient Training Does Not Impact Outcomes in the First 90 Days of Automated Insulin Delivery UseSeema Meighan, Julia L Douvas, Andrew Rearson, et al.
Diabetes Technology & Therapeutics|January 26, 2019
Pediatric Endocrinology Trainees' Education and Knowledge About Insulin Pumps and Continuous Glucose MonitorsBrynn E Marks, Joseph I Wolfsdorf, Gretchen Waldman, et al.
Contemporary Clinical Trials Communications|January 26, 2023
Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort studyJody B Grundman, Shideh Majidi, Amanda Perkins, et al.
Diabetes Technology & Therapeutics|November 7, 2025
Real-World Duration of Dexcom G7 Continuous Glucose Monitor Wear in Youth and Young Adults with Type 1 DiabetesBrynn E Marks, Andrew Rearson, Melissa Andrews Rearson, et al.
Journal of Clinical & Translational Endocrinology|June 5, 2023
Differences in positive expectancy of hybrid closed loop (HCL) insulin delivery systems do not explain racial differences in HCL useJody B Grundman, Amanda Perkins, Maureen Monaghan, et al.
Pageof 5